despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.... april 2013 (20).harvard medical school: "cgrp: a new era for migraine treatment.".
harvard medical school: "cgrp: a new era for migraine treatment.".